Vaxxas
Vaxxas is at the forefront of revolutionizing vaccination technology with its innovative HD-MAP platform, which enhances the efficacy of both existing and next-generation vaccines through a needle-free delivery system. The company is committed to improving global health by making vaccinations more accessible and effective.
Vaxxas
What We Do
A novel vaccination technology that uses a patch with thousands of vaccine-coated microprojections applied to the skin for efficient vaccine delivery.
News & Updates
Vaxxas has announced the expansion of its global intellectual property portfolio for the exclusive manufacture and sale of its needle-free vaccination technology.